Alzheimer’s disease (AD) is a major cause of dementia, disability and death in the elderly. Despite recent advances in our understanding of basic biological mechanisms underlying AD, we do not yet know how to prevent AD or have an approved disease modifying intervention.

Read more

The Target Enablement to Accelerate Therapy Development for Alzheimer’s Disease (TREAT-AD) Program

The goal of the NIA-funded TREAT-AD consortium ( is to translate molecular signatures of late-onset Alzheimer’s disease into…

Read more